Schedule a Virtual Weight Loss Consult Your Path To Results First consultation Discuss your goals with our clinical team Custom protocol Personalized GLP-1 plan for you Ongoing support Check-ins, adjustments, accountability Real results Sustainable loss backed by science Semaglutide GLP-1 receptor agonist Helps control blood sugar and reduce appetite Used for type 2 diabetes and weight management Administered by injection once a week Proven to support weight loss Improves glycemic control $30-36/week Tirzepatide Dual GIP and GLP-1 receptor agonist Targets blood sugar and appetite regulation Approved for type 2 diabetes and obesity treatment Once-weekly injection Shown to provide greater weight loss and glucose control than older medications $47-57/week GLP-1 weight loss FAQ GLP-1 Weight Loss: A Functional Medicine Approach to Sustainable Results Get in Touch or

The dopamine-transporter SPECT substudy embedded in Exenatide-PD3 showed no separation between exenatide and placebo, mirroring the null clinical result and offering no imaging signal of preserved nigrostriatal terminals [2]
Interestingly, GIP has been shown to stimulate glucagon secretion even with high glucose in T2D patients, which implies that inappropriate GIP/GIPR activity contributes to the T2D disease phenotype
Newly differentiated OLs extend their processes and quickly rearrange their membranes to generate internodes around multiple axons through a series of coordinated steps that include: (1) identification and signaling with the target axons, (2) axonal wrapping with membrane outgrowth, (3) transporting membrane components, (4) compacting myelin sheaths, and (5) node establishment (Simons et al., 2024)
Otherwise healthy patients using semaglutide primarily for weight management often find the compounded version adequately reliable, especially from NABP-accredited pharmacies like Strive
Etiam eget dolor ipsum